Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The host vascular and retinal microenvironment engaged by hiPSC-derived vascular reparative cells refers to the complex interaction between therapeutic human induced pluripotent stem cell (hiPSC)-derived cells and the damaged retinal tissue in conditions such as diabetic retinopathy (DR). This engagement is primarily mediated by the SDF-1/CXCR4 signaling axis, where stromal cell-derived factor-1 (SDF-1/CXCL12) is upregulated in the ischemic or diabetic retina, acting as a chemoattractant for CXCR4-expressing vascular reparative cells, including CD34+ progenitors and endothelial colony-forming cells (ECFCs) (Gil et al., 2024, Cells). Upon homing to the site of injury, these cells integrate into the host's retinal vasculature and provide essential trophic support through the secretion of growth factors and anti-inflammatory cytokines, which helps restore vascular integrity and reduce capillary leakage (Park et al., 2020, JCI Insight). Recent studies using Reverse Phase Protein Array (RPPA) analysis have shown that this engagement triggers significant host responses in pathways such as PI3K-AKT-mTOR, glycolysis, and endothelial junction regulation, which are critical for maintaining retinal structure and function (Gil et al., 2025, Cells). Additionally, pharmacological agents like DMHCA have been shown to enhance the mobilization and function of these reparative cells by modulating the bone marrow and retinal microenvironments (Grant et al., 2022, Science Advances). This multi-faceted therapeutic strategy aims to reverse vasodegeneration and neuroretinal dysfunction in ischemic retinopathies.
The therapeutic approach involves the homing of hiPSC-derived vascular reparative cells to the ischemic retinal microenvironment via the SDF-1/CXCR4 chemotactic gradient, followed by their integration into the host vasculature and the secretion of paracrine factors that promote vascular stabilization and neuroprotection.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host vascular and retinal microenvironment engaged by hiPSC-derived vascular reparative cells.